TREATMENT OF PARKINSONISM WITH L-THREO-3,4-DIHYDROXYPHENYLSERINE - A PHARMACOKINETIC STUDY

被引：31

作者：

SUZUKI, T

SAKODA, S

UEJI, M

KISHIMOTO, S

HAYASHI, A

KONDO, T

NARABAYASHI, H

机构：

[1] OSAKA MED CTR,OSAKA,JAPAN

[2] JUNTENDO UNIV HOSP,MATERNAL & CHILD HLTH RES INST,TOKYO,JAPAN

[3] JUNTENDO UNIV HOSP,DEPT NEUROL,TOKYO,JAPAN

来源：

NEUROLOGY | 1984年 / 34卷 / 11期

关键词：

D O I：

10.1212/WNL.34.11.1446

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1446 / 1450

页数：5

共 26 条

[1] FORMATION OF MONOAMINES FROM VARIOUS AMINO ACIDS IN BRAIN AFTER INHIBITION OF EXTRACEREBRAL DECARBOXYLASE [J].

BARTHOLINI, G ;

CONSTANTINIDIS, J ;

TISSOT, R ;

PLETSCHER, A .

BIOCHEMICAL PHARMACOLOGY, 1971, 20 (06) :1243-+

[2]

BARTHOLINI G, 1975, J PHARMACOL EXP THER, V193, P523

[3] EFFECT OF VARIOUS DECARBOXYLASE INHIBITORS ON CEREBRAL METABOLISM OF DIHYDROXYPHENYLALANINE [J].

BARTHOLINI, G ;

PLETSCHER, A .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1969, 21 (05) :323-+

[4] INCREASE OF CEREBRAL CATECHOLAMINES CAUSED BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF PERIPHERAL DECARBOXYLASE [J].

BARTHOLINI, G ;

BURKARD, WP ;

PLETSCHER, A ;

BATES, HM .

NATURE, 1967, 215 (5103) :852-+

[5]

BARTHOLINI G, 1968, J PHARMACOL EXP THER, V161, P14

[6] COMBINED USE OF ALPHA-METHYLTYROSINE AND THREO-DIHYDROXYPHENYLSERINE - SELECTIVE REDUCTION OF DOPAMINE LEVELS IN CENTRAL NERVOUS SYSTEM [J].

CREVELIN.CR ;

DALY, J ;

TOKUYAMA, T ;

WITKOP, B .

BIOCHEMICAL PHARMACOLOGY, 1968, 17 (01) :65-&

[7]

DUNNER DL, 1971, CLIN PHARMACOL THER, V12, P212

[8]

GOODWIN FK, 1970, LANCET, V1, P908

[9]

HIRAI M, 1975, Medical Journal of Osaka University, V26, P51

[10]

INAGAKI C, 1978, BIOCHEM PHARMACOL, V27, P1081

← 1 2 3 →